Martin Clift

Martin gained his PhD from Edinburgh Napier University in 2009, in the area of In Vitro Toxicology (Nanotoxicology). He then conducted his post-doctoral research years in Switzerland (at the University of Bern and University of Fribourg) under the guidance of Prof. Em. Peter Gehr and Prof. Dr. Barbara Rothen-Rutishauser. Since 2015, he has been part of the In Vitro Toxicology Group at Swansea University Medical School.

Focussing upon the (human) inhalation toxicology of particulate, his core competence lays in both (i) particle and fibre toxicology and (ii) the creation/use of advanced in vitro systems (healthy and diseased) that mimic the human lungs' anatomy and physiology. In general, Martin’s research is focused on the (nano)particle-mammalian cell interaction, with a view to determining the mechanistic toxicological, immunological and genotoxic effects that (nano)particles may cause to humans.

Martin serves as the Editor-in-Chief for 'Fibres', as well as an Associate Editor for the 'Journal of Nanobiotechnology'. He is further an editorial board member for 'Particle and Fibre Toxicology', 'Food and Chemical Toxicology', and 'Mutagenesis'. Martin is the Chair of the UK In Vitro Toxicology Society, and a member of the British Toxicology Society Sub-Scientific Committee. Martin is a Fellow of the European Respiratory Society, Member of the Royal Society of Biology and the UK Environmental Mutagenesis Society.